|Articles|October 19, 2015
Rudolph Navari on Preventing CINV With Olanzapine
Author(s)Rudolph Navari
Rudolph Navari, discusses a study of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.
Advertisement
Rudolph Navari, director, Cancer Care Program in Central and South America, World Health Organization, professor of medicine, Indiana University School of Medicine-South Bend, discusses a study of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
A Simple Calf Exercise for Patients with Cancer, From an Oncology Physical Therapist
2
Four Ovarian Cancer Recurrences Taught Me What Survivorship Really Means
3
Nurse Builds Prostate Cancer Support Community Through Compassion
4
Oncology Nurse's Quiet Acts of Kindness Restore Patients' Humanity
5